Insider buy: Camp4 Therapeutics Corp (CAMP) CMO adds 6,551 shares
Rhea-AI Filing Summary
Camp4 Therapeutics Corp Chief Medical Officer Yuri Maricich purchased 6,551 shares of common stock on August 3, 2026 in the second closing of a private placement at $1.65 per share under a Securities Purchase Agreement. After this transaction, he directly holds 12,611 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,551 shares
Net Buy
1 txn
Insider
Maricich Yuri
Role
Chief Medical Officer
Bought
6,551 shs ($11K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 6,551 | $1.65 | $11K |
Holdings After Transaction:
Common Stock — 12,611 shares (Direct)
Footnotes (1)
- F1. On August 3, 2026, the reporting person acquired shares in the second closing of a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025, as amended on August 3, 2026, by and among the Issuer and certain institutional investors and certain directors, employees, and consultants, at a purchase price of $1.65 per share.
Key Figures
Shares purchased: 6,551 shares
Purchase price: $1.65 per share
Shares held after purchase: 12,611 shares
3 metrics
Shares purchased
6,551 shares
Common stock acquired on August 3, 2026 in a private placement
Purchase price
$1.65 per share
Price paid in the August 3, 2026 private placement
Shares held after purchase
12,611 shares
Direct Camp4 common stock holdings following the reported transaction
Key Terms
private placement, Securities Purchase Agreement, institutional investors
3 terms
private placement financial
"acquired shares in the second closing of a private placement by the Issuer"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Securities Purchase Agreement financial
"pursuant to the terms of a Securities Purchase Agreement, dated as of September 9, 2025"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
institutional investors financial
"by and among the Issuer and certain institutional investors and certain directors"
Institutional investors are large organizations, like pension funds, insurance companies, and mutual funds, that invest huge amounts of money on behalf of many people. Their decisions can influence the economy because they buy and sell big chunks of stocks, bonds, or other assets. They matter because their actions can affect market prices and trends.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did CAMP report for Chief Medical Officer Yuri Maricich?
Yuri Maricich, Camp4 Therapeutics Corp’s Chief Medical Officer, bought 6,551 common shares on August 3, 2026. The shares were acquired in the second closing of a private placement at $1.65 per share under a Securities Purchase Agreement.
What is the context of the private placement referenced in CAMP’s Form 4 filing?
The Form 4 notes that shares were acquired in the second closing of a private placement under a Securities Purchase Agreement dated September 9, 2025, amended August 3, 2026, involving the issuer, institutional investors, and certain directors, employees, and consultants.